Becker Fund Manager: 'Howard Hughes and Pfizer Will Head Higher' - Presented by: The Aol. On Network

Pfizer's stock may currently be out of favor, but the drug giant's fortunes will soon turn due to its strong cash flow and undervalued pipeline, said Andy Murray, portfolio manager for the Becker Value Equity Fund. Murray added that Pfizer could make another run at AstraZeneca due to its solid balance sheet.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.35 0.09 ▼ 0.55%
VALE $ 8.80 0.77 ▲ 9.59%
PBR $ 10.19 0.41 ▲ 4.19%
MSFT $ 47.60 0.64 ▼ 1.33%
AAPL $ 125.80 2.90 ▼ 2.25%
S $ 4.99 0.16 ▼ 3.11%
QQQ $ 107.45 1.78 ▼ 1.63%
BABA $ 79.54 1.05 ▼ 1.30%

As of 5/5/2015, 04:15 PM